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Abstract. Selenium (Se) is essential micronutrient involved in several physiological processes. In many regions around 
the world, a suboptimal intake of Se has been reported in several health conditions, also in pediatric age. Studies on 
association between Se level and diseases in children reported contrasting results. We took an aim to perform a 
systematic review of literature and provide evidence-based conclusion on the magnitude of Se deficit in endocrine 
diseases in children. PubMed, ISI WoS, and Scopus databases were searched to identify eligible studies, published until 
July 25, 2019. Methodological quality was assessed using Newcastle–Ottawa Scale. After careful selection, 13 eligible 
studies were included. Majority were conducted in Turkey (n=5) and Iran (n=5), and sample size varied from 61 to 628 
children, with a mean (±SD) age of cases from 5.1±1.6 months up to 13.8±4.5 years. Eleven studies focused on different 
thyroid diseases, and two on children with type 1 diabetes mellitus (T1DM). In goitrous patients, Se level ranged from mean 
(±SD), 25.71±20.68 μg/L to 114.9±34.1 μg/L, while in patients with T1DM was 20.9±12.9 μg/mL and mean (95% CI)=58.4 
μg/L (55.0–63.09). We may conclude that goiter and thyroid dysfunction are prominent signs of Se deficiency in children. 
Although deficiency of iodine and selenium are usually combined in some area, our systematic review showed that Se 
deficiency is important goitrogenic factor in school children. Further randomized controlled trials are needed to adequately 
explore the role of Se in endocrine disorders in children, across different populations and regions. 
Key words: Selenium, endocrine, thyroid, diabetes, pediatric, systematic review. 
Introduction  
Selenium (Se) is a trace mineral and one of the essential 
micronutrients involved in several physiological pro-
cesses [1]. It is a constituent of selenoproteins many of 
which are engaged in protection against oxidative stress 
[2], and a cofactor of many enzymes involved in several 
major metabolic pathways [3–6]. It is involved in thy-
roid metabolism as a cofactor of the glutathione peroxi-
dase (GPx), protecting the thyroid gland against oxida-
tive stress, and iodothyronin deiodinase enzymes, con-
verting thyroxine (T4) to triiodothyronine (T3) [4, 6–9]. 
Being so important in human organism, the deficiency 
of Se can endanger human health and lead to misbal-
ance of many biochemical processes further resulting in 
disease [10, 11].  
Se intake and its level in the body depend on the per-
son’s diet, where major sources of Se intake are plant 
foods, meat and meat products, nuts (Brazil nuts), cereals, 
fish and shellfish [12, 13]. In many regions around the 
world, people are exposed to inadequate content of Se in 
food because of the low Se content in the soils where 
plants and animals are grown [6, 14, 15]. Activity of Se-
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dependent thyroid enzymes, in case of Se deficiency, could 
cause impairment of the thyroid metabolism even in the 
situation of adequate iodine intake [16]. Also, deficit of Se 
has been associated with the poor immune response [17, 
18]. In general, association of Se deficiency with many 
diseases has been documented, among which the increased 
risk of thyroid cancer, infections and immunodepression, 
diabetes, Keshan’s disease and endemic myxedema cretin-
ism, mostly suggested to be due to the lack of protection 
against the oxidative stress [15, 19, 20]. 
Suboptimal intake of Se has been reported in several 
health conditions also in the pediatric age [21]. In Hash-
imoto’s thyroiditis in childhood, the deficiency of Se 
may promote initiation or progression of the disease 
[17, 22, 23]. Also, in other conditions of thyroid dys-
function in children, congenital hypothyroidism and 
goiter, different levels of serum Se have been demon-
strated among cases and controls [16, 24]. Lower levels 
of Se and consequent oxidative damage are one of the 
possible factors involved in the etiology of diabetes 
mellitus in children [25]. Lower Se levels have also 
been reported in children with iron-deficiency anemia, 
dilated cardiomyopathy and acute lymphoblastic leuke-
mia, when compared to the matched healthy controls [26, 
27]. Low selenium levels also affected early neonatal 
morbidity in premature infants [28], and has been associat-
ed with hypoxia and respiratory diseases [29].  
Studies on the association between Se level and dis-
eases in children reported significantly lower levels of 
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Se in cases or no difference between levels in cases and 
controls. Since endocrine health and hormonal balance are 
of great importance, particularly in the childhood, for nor-
mal growth and development, we took an aim to perform a 
comprehensive and systematic review of the literature in 
order to provide a general overview and draw evidence-
based conclusion on the prevalence and magnitude of the 
Se deficit in endocrine diseases in children. 
Material and Methods 
Literature Search Strategy 
In order to retrieve primary studies, a systematic biblio-
graphic search was conducted in accord with the Pre-
ferred Reporting Items for Systematic Reviews and Me-
ta-Analyses (PRISMA) guideline [30] through a multi-
engine search of PubMed, ISI Web of Science (WoS), 
and Scopus databases. For initial search of the PubMed 
database, the following combination of subject headings 
and text words was used: (((selenium OR selenate OR 
“selenium derivative” OR “selenium compound*” OR 
“antioxidant cocktail*” OR selenite OR “sodium selenite” 
OR selenomethionine OR selenocysteine OR ebselen OR 
“selenious acid” OR “selenium-binding protein*” OR 
“trace element*”) AND (lack OR deficit OR deficiency 
OR reduction OR shortage OR decreas* OR insufficien*)) 
AND (pediatric* OR children OR child OR preschool OR 
school OR infan* OR adolescen* OR young*)). The re-
maining two databases were searched using appropriately 
modified PubMed query (detailed search queries are avail-
able upon request). Our search was restricted to studies 
conducted on humans and published up until July 25, 2019 
in English, Italian or Serbian language. 
Study Selection 
Records from three different electronic databases were 
retrieved and cross-linking was performed in order to 
remove duplicates. Titles and abstracts of the identified 
records were screened and full texts of the initially eli-
gible articles were obtained and evaluated for final eli-
gibility. All of the steps are documented in the PRISMA 
flow diagram. 
Studies were considered eligible if they met the fol-
lowing inclusion criteria: cross-sectional, case-control 
or cohort study design; studies on children or adoles-
cents ≤18 years old with endocrine disease; studies that 
evaluated serum/plasma levels of selenium. Other re-
views, letters, commentaries, editorials, case studies, 
studies conducted on cell or animal model were further 
excluded. Justification for the exclusion of records was 
specified and any disagreement in opinion between re-
viewers was resolved through discussion.  
Data Extraction, Synthesis and Quality Assessment 
Extraction of the data from each eligible study was con-
ducted and data was entered into standard Excel form in 
order to synthesize and present the results. Data on first 
author’s name, year of study publication, country where 
the study was conducted, type of study design, type of 
endocrine disorder, total number of children, their age, 
percent of male participants, number of cases/controls, 
Se source (plasma or serum), measurement method of 
Se, measured concentration of Se (in cases/controls), 
reported statistical findings (if available). Due to the 
absence of common statistical estimates of effect in the 
included studies, we were unable to perform a quantita-
tive pooling of data through meta-analysis thus we used 
a narrative synthesis to describe the findings. 
Methodological quality of the included studies was 
assessed using the Newcastle–Ottawa Scale (NOS) for 
case-controls studies [31] and the adapted version by 
Herzog et al. [32] for the cross-sectional studies. Three 
main perspectives of the methodological quality of each 
included study were evaluated: selection of the study 
groups; comparability of the groups; and the ascertain-
ment of outcome and exposure for cross-sectional and 
case-control studies, respectively. This tool uses a star 
system to assign a maximum of nine stars for case-
control and ten for cross-sectional studies, across the 
evaluated domains. Studies were classified as good (≥6 
stars), moderate (3-5 stars) and low (<3 stars) quality 
based on the maximum score. Detailed instructions for 
using this tool are provided elsewhere [33]. 
Results 
Literature Search and Study Selection 
A total of 4272 records were identified through the 
search of PubMed, ISI WoS and Scopus databases. Af-
ter removing duplicates, 3312 titles and abstracts were 
screened, leading to a careful selection of 239 full text 
articles to be assessed for further eligibility. Of these, 
226 articles were excluded for not meeting the inclusion 
criteria, leaving 13 eligible studies to be included in the 
qualitative synthesis [34, 35, 44–46, 36–43]. Detailed 
process of literature search and study selection is pre-
sented in Figure 1. 
Characteristics of the Studies 
Majority of the included studies were conducted in Tur-
key (n=5) and Iran (n=5), and by one in Poland, Ethio-
pia and Democratic Republic of the Congo (Table 1). 
Publication years ranged from 1990 [46] to the most 
recent one from 2018 [44]. Most of the studies used 
cross-sectional study design [34–41] while the remain-
ing five were case-control studies [42–46]. Sample size 
varied from 61 [43] to 628 children [38] with mean age 
of cases spanning from 5.1±1.6 months [44] to 13.8±4.5 
years [43]. Percentage of boys was different across the 
included studies, with a minimum of 21.95% [42] to a 
maximum of 71.25% [46]. Considering the investigated 
endocrinological disease, 11 studies focused on differ-
ent thyroid disorders, namely goiter [34–41] and hypo-
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thyroidisms [42,44], while the remaining two explored 
selenium status in children with the type 1 diabetes 
mellitus (T1DM) [43, 45]. Number of cases ranged from 
48 [35, 39] to 280 [38] goitrous, and 35 [43] to 87 [45] 
children with T1DM. 
Details on the selenium concentrations and main 
findings from the included studies are summarized in 
Table 2. Atomic absorption spectrometry was the most 
widely used method to measure the level of Se in serum 
[34–38, 42, 44, 46] and plasma [39–41, 43, 45]. Mean 
concentration of Se was different across the investigated 
populations and diseases. For goitrous patients, Se levels 
ranged from 25.71±20.68 μg/L [34] to 114.9±34.1 μg/L 
[36], while in patients with T1DM were 20.9±12.9 μg/mL 
[43] and 58.4 μg/L [45]. 
In general, level of Se was lower in children with 
goiter [35, 36, 39, 41] and in children with T1DM [43] 
or there was no difference reported between cases and 
controls in children with goiter and Hashimoto thyroidi-
tis [38, 42]. Studies that had investigated correlation of 
Se level and several clinical parameters reported differ-
ent findings, negative [34, 41], positive [39, 42], mixed 
[38, 44] some positive and some negative, and no sig-
nificant correlation [35, 37, 40] in thyroid patients. In 
particular, a study by Gashu and colleagues reported 
that serum Se was negatively associated with T4, but 
positively with T3 concentration, and that a unit in-
crease in concentration of Se could increase the serum 
T3 concentration by a factor of 0.16 [38]. On the other 
side, Cinaz et al. demonstrated the lack of correlation 
between serum Se levels and thyroid function tests in 
their study [35]. In two studies conducted on diabetic 
patients, a negative correlation was reported between Se 
level and glycosylated hemoglobin (HbA1c) level [43], 
while Salmonowicz et al. reported non-significant corre-
lations across different parameters [45]. Overall, the 
body of evidence in our review was characterized by a 
moderate to high quality level. Methodological quality 
of the included studies was good, especially of those 
cross-sectional study design, where two studies [34, 38] 
scored maximum stars across all evaluated domains. 
Case-control studies were mostly of moderate to good 
methodological quality (Table 3).  
 
Fig. 1 Flowchart depicting literature search and study selection process 
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Table 1 General characteristics of the included studies 









Number (n) of cases 
and controls 
Aydin, 2002 [34] Turkey Cross-
sectional 





Cases (56);  
controls (17) 
Cinaz, 2004 [35] Turkey Cross-
sectional 
Goiter 165 Mean±SD= 
 9.04 ±1.91 














251 Range=9–11 123 
(49.01%) 
Chidren from cities: 
Ankara (62), 
Kastamonu (64), 
Bayburt (59), and 
Kastamonu (66) 
Gashu, 2016 [38] Ethiopia Cross-
sectional 
Goiter 628 Range=4.5–5; 
mean±SD= 
 4.74 ± 0.15 
311 
(49.52%) 
Cases (280);  
controls (348) 
Giray, 2001 [39] Turkey Cross-
sectional 
Goiter 121 Range= 15–18 52  
(42.98%) 
Cases (48); controls in-
region controls (49), 















Goiter 168 Range = 6-13; 
mean±SD=  








Iran Cross-control Hashimoto’s 
thyroiditis and 
hypothyroidism 













and controls (30) 













Iran Cross-control Congenital 
hypothyroidism 
99 Cases, range= 0.25–1, 
mean±SD=  




0.52 ± 0.12 
49  
(49,50%) 




Poland Cross-control Type 1 diabetes 
mellitus 
(T1DM) 





13.2 ± 3.7; and 
control groups 
range=10.5–18, 
mean±SD=14.8 ± 2.2 
79  
(50,97%) 
Cases (87);  
controls: siblings of the 
patients with T1DM  
(27 children) and 















Cases (28);  
controls (52) 
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Table 2 Selenium concentrations and main findings from the included studies 







Selenium concentrations in cases 
and controls 
Reported correlations 






Negative correlation was reported between 
thyroid volume and Se level  
(r = 0.32, ρ <0.05). 
Cinaz, 2004 [35] Serum 
Spectrophotometer 
(Unicam 939 AA) 
Goitrous, mean±SD= 52.39± 
10.87 ng/mL; non-goitrous group, 
mean±SD= 58.94±15.42 ng/mL; 
p=0.002 
Serum Se levels did not correlate with the 
thyroid function tests, and T3, T4, and 
TSH levels are found to be similar in 







CTA 2000, AAS) 
Goiterous, mean±SD=  
114.9 ± 34.1 μg/L; non-goitrous, 














57.54±14.60ng/mL; and Trabzon, 
mean±SD= 52.22±14.30ng/mL 
No significant correlations between serum 
Se concentrations and studied parameters 
(i.e., Thyroid volume, thiocyanate (SCN−) 
overload, thyroid hormones, sensitive TSH 
(sTSH) levels, and urinary iodine 
concentrations (UICs)) was detected. 





NR (mean Se concentrations of 
goitrous and non-goitrous children 
were not significantly different, 
p>0.05). Entire study population, 
median=61.4 μg/L,  
range=10.7–290.9 μg/L 
Serum Se was negatively correlated to T4 
concentration (r=−0.22, p<0.01). 
Giray, 2001 [39] Plasma 
Spectrofluorometric 
method 
Total goiter group, mean±SD= 
67.1±10.9µg/L; total in-region 
control, mean±SD= 75.0±14.6µg/L; 
and out-region control group, 
mean±SD= 75.3±12.8µg/L 
In “all severely deficient children” a 
positive correlations of urinary iodine and 






Goitrous, mean±SD= 62.7 g/L; non-
goitrous, mean±SD= 60.8 g/L; p = 
0.42 
No correlation was found between serum 
Se concentration and baseline data of the 







Goitrous, mean±SD=  
66.86±21.82 μg/L; non-goitrous 
children, mean±SD= 
 76.67±23.33 μg/L; p=0.006 
In goitrous children, Se level was reversely 
correlated with age (r=−0.24, p=0.02), 
BMI (r=−0.20, p=0.05) and body surface 
area (r=−0.26, p=0.01) and was positively 






trAA 700, Analytik 
Jena AG, Jena, 
Germany) 
Hashimoto’s thyroiditis, mean±SD= 
91.6±17.7µg/L; hypothyroidism, 
mean±SD= 85.9±14.8 µg/L; 
controls, mean±SD= 97.2±29.4µg/L 
Se levels did not show any significant 
correlation with glutathione peroxidase but 
it had a significant correlation with  
selenoprotein P (r = 0.34, p= 0.02) 
Ozenc, 2015 [43] Plasma 
Atomic absorption 
spectrophotometry 






There was a negative correlation between 








10.5 ± 0.65 mg/L; controls, 
mean±SD=55.17 ± 8.55 mg/L; 
 p = 0.01 
No statistically significant correlations 
were found between Se concentration and 
TSH level (r = 0.13, p = 0.29), and FT4 
concentration (r = 0.07, p = 0.54). There 
was a significant correlation between 
prooxidant-antioxidant balance (PAB) 
value and serum Se concentration, and also 
between Se concentration and MCV (for 









Patients with T1DM, mean  
(95% CI)= 58.4μg/L (55.0–63.09); 
siblings of patients with T1DM, 
mean, (95% CI)=53.45μg/L (46.09–
65.21); healthy controls, mean  
(95% CI)= 53.3μg/L (45.78–70.17) 
In patients with T1DM no significant 
correlations were found between Se and: 
HbA1c (r=0.2, p=0.07), age (r = 0.01,  
p = 0.89), TC (r = –0.05, p = 0.72), TG  
(r = –0.07, p = 0.59), HDL-C (r = –0.12,  
p = 0.45), LDL-C (r = –0.02, p = 0.89), 





 443 ± 188 nmol/L; controls, 
mean±SD=343 ± 176 nmol/L; p>0.1 
NR 
NR= not reported; SD=standard deviation; T1DM=Type 1 diabetes mellitus 
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Discussion 
Although discovered more than two centuries ago, Se 
and its role in health and disease remained underesti-
mated and not fully elucidated. Endemic deficiency in 
large areas of central Asia clearly demonstrated its criti-
cal importance for survival. There are two well estab-
lished entities of selenopenia: Kashin-Beck osteochon-
dropathy and Keshan disease, a severe cardiomyopathy 
characterized by fulminant heart failure [47, 48]. The 
later mainly affects young children and women in 
childbearing age and it is apparent in population with 
particularly low Se intake (<15 μg/d), in some areas of 
China. It is noteworthy to mention that there is a rela-
tively narrow range of Se intake, between deficiency 
(<30 μg/d) and toxicity (>900 μg/d) [49]. Numerous 
beneficial effects are attributed to Se and are extensively 
investigated in adults: antioxidant effects, correct func-
tioning of the immune system, antiviral effects (nowa-
days of special interest), decrease in the risk of miscar-
riage, effects on bone metabolism, regulation of normal 
spermatozoa development and motility, beneficial effect 
on mood [6, 47, 50, 51]. Interventional studies with Se 
in different pathological conditions in pediatric age are 
very rare. 
In the current review, we selected 13 articles with 
the aim to investigate interdependence of Se levels and 
clinical presentation of endocrine diseases in children 
and adolescents. Majority of them refers to thyroid dis-
orders and thyromegaly. Only two were performed in 
children with T1DM. It is expected finding taking into 
account that thyroid represents the organ which is most 
abundant in Se per gram of tissue, even richer than the 
brain, due to a high content of selenoproteins [6]. Ac-
cording to these data, the most frequent and severe Se 
deficiency is present in some parts of Africa (Northern 
Zair and Ethiopia) and Asia (China, Iran and Turkey) 
[38, 46, 49]. In a cross-sectional study on 628 children 
from Gonder, town of the Amhara region of Ethiopia, a 
goiter was found in 44,6% of them. The majority of 
children (88,6%) had suboptimal iodine supply 
(<100 μg/l). The presence of Se deficiency (serum Se 
<70 μg/l) was recognized as a problem in 57.8% of 
children [38]. Also, serum Se was negatively associated 
with T4 level in young children from this region. 
Vanderpas et al. emphasized that combined iodine and 
Se deficiency could be associated with the elevated fre-
quency of myxedematous cretinism as a consequence of 
thyroid involution [46]. Similarly to observations from 
China, the distribution of Se deficiency was highly vari-
able such that the deficiency and toxicity occurred in 
populations living just about 20 km apart, depending 
strongly on the geochemical characteristics of the soil in 
these specific areas [46, 49]. 
As mentioned above, in some severely iodine-
deficient areas a concomitant deficiency of Se aggra-
vates hypothyroidism leading to the myxedematous 
cretinism [14, 46]. On the other hand, an adequate sele-
nium supply protects the thyroid from damage due to 
excessive iodine exposure, thus a selenium deficit 
should be corrected before the introduction of iodine 
supplementation when both deficits coexist [14, 52, 53]. 
Selenium deficiency was negatively associated with 
serum T4, but almost all children had normal level of 
T3. Vanderpas et al. suggested that in iodine-deficient 
subjects, Se deficiency may help maintaining the T3 
concentration at normal level [46]. We find that it is just 
opposite from what could be expected, taking into ac-
count the role of Se containing deiodinase DIO1 in con-
version of T4 to T3. Improved peripheral deiodination 
of T4 should provide increase in T3/T4 ratio that is con-
firmed after Se supplementation in school children from 
Se deficient area, evident from the study of Contempre 
et al. [54]. From 11 studies concerning the interdepend-
ence of Se level and thyroid status, two demonstrated a 
positive correlation, one to T4 and another to T3. In the 
study of Gashu et al., Se concentration was negatively 
associated to T4 concentration, but positively to serum 
T3 concentration [38]. It is difficult to explain contra-
dictory data about T4 and T3 levels, so further studies 
conducted on larger cohorts are necessary. 
Endemic goiter is present in almost all regions of 
Turkey, while the highest prevalence is reported in the 
Black Sea region, reaching over 50%, particularly in 
Table 3 Methodological quality of the included studies 
First author, year Study design Selection Comparability Outcome/Exposure 
Aydin, 2002 [34] CS ***** ** *** 
Cinaz, 2004 [35] CS **** ** *** 
Dabbaghmanesh, 2007 [36] CS ***** * *** 
Erdogan, 2001 [37] CS *** ** *** 
Gashu, 2016 [38] CS ***** ** *** 
Giray, 2001 [39] CS *** ** *** 
Hashemipour, 2008 [40] CS **** ** *** 
Keshteli, 2009 [41] CS **** ** *** 
Nourbakhsh, 2015 [42] CC *** * ** 
Ozenc, 2015 [43] CC  * ** 
Rostami, 2018 [44] CC **** * ** 
Salmonowicz, 2014 [45] CC *** * ** 
Vanderpas, 1990 [46] CC * * ** 
CS = cross-sectional; CC = case-control.  
Note: A study can be awarded a maximum of four stars for case-controls and five stars for cross-sectional study within the selection 
category. A maximum of two stars can be given for comparability and three stars for outcome/exposure categories. 
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some high-altitude mountain villages. Iodization of salt 
was introduced in Turkey in 1968, but IDD (Iodine De-
ficiency Disorders) are far from eradication in this coun-
try [39]. For comparison, iodization of salt in former 
Yugoslavia started in 1956 and then reevaluated and 
reinforced in 1993, when the amount of iodine was dou-
bled [55]. Giray et al. evaluated Se concentrations in 
goitrous children with severely and moderately iodine 
deficiency in comparison with normal and mildly iodine 
deficient non goitrous children serving as control, and 
found significantly lower Se values in the goitrous 
group. The same study showed lower level of antioxi-
dant blood enzymes glutathione peroxidase, catalase 
and superoxide dismutase, suggesting alterations in an-
tioxidant defense system and multiple micronutrient 
deficiency [39]. All Turkish studies reported high goiter 
persistence, despite normalization of the iodine status. 
Goitrous children from Turkey had moderate to severe 
Se deficiency in iodine depleted as well as in the iodine 
repleted areas [34, 39]. Similar to Turkish experience, 
the Iranian studies in former endemic areas showed high 
percentage of goiter in school children. The deficiency 
of both trace elements, iodine and selenium is even 
more severe than what was reported in Turkey. The 
most affected endocrine gland by Se deficiency was 
thyroid. Studies from Turkey, as well as from Iran re-
ferred goiter in children as the most prominent clinical 
sign of selenopenia (9 out of 11 studies). Unfortunately, 
even in the cross-sectional studies, Se level was not 
measured in the whole group, but only in goitrous chil-
dren, selected by palpation of the gland when some se-
verely Se deficient children might be omitted. In select-
ed children with thyromegaly the widest difference in 
Se level between goitrous and non-goitrous children 
was found in the study of Aydin et al., 25.71 μg/L and 
47.76 μg/L, respectively [34]. The authors found signif-
icant negative correlation between thyroid volume and 
Se levels. On the other side, Gashu [38] and Hashemi-
pour [40] did not find significant difference in Se levels 
between goitrous and non-goitrous children. Obviously, 
the role of other goitrogens in food or another trace-
element deficiency should be additionally evaluated. 
Extremely low Se level was found by Rostami et al. 
in the group of hypothyroid children [44]. Only one 
pediatric study from Iran, among selected in our review, 
referred to autoimmune thyroid disease. It failed to find 
significant difference in Se levels between patients with 
Hashimoto's thyroiditis and normal controls [42]. It is 
expected that having a normal Se level provides effec-
tive thyroid function and diminishes oxidative stress in 
thyroid cells, thus protecting thyroid from autoimmuni-
ty. In adult patients with chronic autoimmune thyroiditis 
from Germany and Greece, a Se supplementation de-
creased thyroid peroxidase antibodies [56, 57]. A strik-
ing majority of these patients reported an improvement 
in mood and well-being after 6 months of combined 
treatment (LT4+Se) [57]. In children, this effect was not 
confirmed [42]. However, a recent meta-analysis did not 
present sufficient data on clinical efficacy of selenium 
supplementation in chronic autoimmune thyroiditis in 
adults, and the authors concluded that further investiga-
tions are warranted [51]. 
Only two studies on children with T1DM were in-
cluded as eligible in our systematic review [43, 45]. 
Hyperglycemia in diabetes increases or potentiates the 
oxidative stress. In the Turkish study a significantly 
lower levels of Se were found in diabetic children in 
comparison with controls and it correlated negatively 
with the HbA1c. Expectantly, the level of Se-containing 
enzyme, GPx was significantly higher in diabetic chil-
dren [43]. We may explain this finding by enhanced the 
need for GPx antioxidant activity that consumes more 
Se in diabetic subjects. In the study of Polish authors, on 
a larger group of patients, difference in the GPx activity 
between diabetic children and non-diabetic controls was 
not confirmed [45]. It would be of interest to determine 
and to compare Se levels in different stages of diabetes 
in children (prediabetes, at admission, in acute metabol-
ic decompensation, remission period, permanent stable 
or brittle diabetes). These results could be of immense 
practical importance for the prevention strategies. 
Strengths and Limitations  
To the best of our knowledge, this is the first review about 
the selenium deficiency in endocrine diseases to focus 
specifically on pediatric population, and thus has several 
strengths. First, we used a comprehensive methodological 
approach and careful selection of the studies, and also did 
an extensive data extraction from the included studies 
and provided a synthesis of evidence on this issue. Sec-
ond, our search covered wide time interval and several 
different populations of children across different regions 
and countries. Further, the methodological quality of 
included studies was of moderate to high level, which 
was confirmed by a critical evaluation of their study 
design using appropriate evaluation scale.  
However, there are some limitations that should be 
considered when interpreting our results. We only 
searched for published studies in English, Italian and 
Serbian language, thus we cannot exclude the possibility 
of publication bias and also, this might have affected the 
geographical representation of the studies. We did not 
limit our search to any particular endocrine disease 
since we wanted to present the general overview of the 
Se levels in endocrine disorders in children, available so 
far. Observational nature of the included studies is an-
other limitation that should be acknowledged. Further 
randomized controlled trials are needed to adequately 
explore the role of Se in disorders of the endocrine sys-
tem. 
We were unable to perform a quantitative pooling of 
the data through a meta-analysis due to the lack of effect 
estimates in the included studies. Additionally, most of 
the included studies investigated populations from low 
and middle income countries thus our findings might 
not be widely applicable to other populations, particu-
larly those from high-income countries, due to the pos-
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sible difference in life-style, habits and particularly in 
diet. In fact, lack of information on dietary habits and Se 
intake from food as well as the genetic background of 
the participants might have influenced our findings, but 
these were not available to us since they were not ex-
plored in the included studies. This further underlines 
the need for more research in that direction. In particu-
lar, since the incidence of endocrine diseases, especially 
diabetes is rising across the world, a trans-regional mul-
ticenter studies on children to explore Se levels across 
different populations and regions are highly desirable.  
Conclusions 
We may conclude that thyroid disorders, goiter and thy-
roid dysfunction are prominent signs of Se deficiency in 
school children. Critical importance of thyroid function 
on early brain development, somatic growth and matu-
ration, as well as for appropriate energy level for an 
active life, is impetus for further thorough investigation 
of selenostasis in wide population, especially in children 
and adolescents. For thyroid autoimmunity, there are 
insufficient data in the pediatric age. Although deficien-
cy of iodine and selenium are usually combined in some 
area, our systematic review showed that Se deficiency is 
important goitrogenic factor in school children. Defi-
ciency of other trace elements, like Zn (cofactor of TSH 
receptor) and iron (cofactor of thyroid peroxidase en-
zyme), necessary for appropriate thyroid function, 
should be further investigated. 
The role of Se in autoimmunity is attractive and prom-
ising, but it is underinvestigated and its clinical use is not 
recommended routinely. Some selenopenic subjects with 
autoimmune diseases could have beneficial effects. Wider 
use of Se is not advised because of its potential toxic ef-
fects. High Se intake may lead to selenosis or increase risk 
of type 2 diabetes mellitus, glaucoma, cancer, cardiovascu-
lar mortality and peripheral arterial disease [6]. Thus, it is 
particularly important to ensure optimal and balanced diet, 
in both macro and micronutrients, for better metabolic 
health from an early age. 
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